Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2001 April;67(4) > Minerva Anestesiologica 2001 April;67(4):307-9

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA ANESTESIOLOGICA

A Journal on Anesthesiology, Resuscitation, Analgesia and Intensive Care


Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,623


eTOC

 

SEPSI  SMART 2001FREEfree


Minerva Anestesiologica 2001 April;67(4):307-9

Copyright © 2009 EDIZIONI MINERVA MEDICA

language: Italian

Antibiotic therapy in Italy

Malacarne P., Rossi C.

Azienda Ospedaliera Pisana II Rianimazione *Istituto di Ricerche Farmacologiche «M. Negri» Laboratorio di Epidemiologia Clinica


FULL TEXT  


Data concerning antibiotic therapy in italian ICUs are presented. These data were not directly measured: they have been derived from a previous study on costs of intensive care treatments. 78% of 1065 patients received antibiotic therapy. Empirical therapy was started in 82% of septic patients. 93% of septic patints had at least one antibiogram. In 96% of cases, 2 or more antibiotics were given. 85% of surgical non septic patients received antibiotic prophylaxis for an average of 3.6 days, with a 3rd generation cephalosporine in the majority of cases. 60% of medical non septic patients rceived antibiotic prophylaxis for an average of 6.2 days, mostly with a 3rd generation cephalosporine. These data raise doubts about the proper use of prophlaxis. These data can be considered a useful starting point for the development of a program of surveillance of infections in Italian ICUs.

top of page

Publication History

Cite this article as

Corresponding author e-mail